Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants

Arthritis and Rheumatism

Volumn 44, Issue 5, 2001, Pages 1089-1095

  Noyszewski, Elizabeth A ^a   Wroblewski, Krzysztof ^a   Dodge, George R ^b   Kudchodkar, Sagar ^a   Beers, Jennifer ^a   Sarma, A V S ^a   Reddy, Ravinder ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GALACTOSAMINE; GLUCOSAMINE; HEXOSAMINE; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARBON NUCLEAR MAGNETIC RESONANCE; CARTILAGE; CARTILAGE CELL; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE;

ANIMALS; CARBON ISOTOPES; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; CHONDROITIN SULFATES; GALACTOSAMINE; GLUCOSAMINE; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 0035025558     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200105)44:5<1089::AID-ANR189>3.0.CO;2-9     Document Type: Article

References (28)

1. Brandt KD, Slemenda C. Osteoarthritis. A. Epidemiology, pathology, and pathogenesis. In: Schumacher HR Jr, editor. Primer on the rheumatic diseases. 10th ed. Atlanta. Arthritis Foundation; 1993. p. 184-8.
2. Evans CH, Robbins PD. Potential treatment of osteoarthritis by gene therapy. Rheum Dis Clin North Am 1999;25:333-44.
3. Vacanti CA, Upton J. Tissue-engineered morphogenesis of cartilage and bone by means of cell transplantation using synthetic biodegradable polymer matrices. Clin Plast Surg 1994;21:445-62.
4. Brittberg M. Autologous chondrocyte transplantation. Clin Orthop 1999;367 Suppl:S147-55.
5. Trelstad RL, Kemp PD. Matrix glycoproteins and proteoglycans. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 4th ed. Philadelphia: WB Saunders; 1993. p. 35-57.
6. Eyre DR, Wu JJ. Collagen structure and cartilage matrix integrity. J Rheumatol Suppl 1995;43:82-5.
7. Mankin HJ, Brandt KD. Biochemistry and metabolism of articular cartilage in osteoarthritis. In: Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, editors. Osteoarthritis: diagnosis and medical/surgical management. Philadelphia: WB Saunders; 1992. p. 109-54.
8. Glucosamine: panacea or patent medicine? Jt Letter 2000;6:1-9.
9. Sandy JD, Gamett D, Thompson V, Verscharen C. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem J 1998;335:59-66.
10. Wehrli FW, Wirthlin T. Interpretation of carbon-13 NMR spectra. London: Heyden and Sons; 1976.
11. Roden M, Shulman GI. Applications of NMR spectroscopy to study muscle glycogen metabolism in man. Annu Rev Med 1999; 50:277-90.
12. 13C-magnetic resonance spectroscopy to studies of neuronal/glial relationships. Dev Neurosci 1998;20:277-88.
13. Beylot M, Peroni O, Diraison F, Large V. New methods for in vivo studies of hepatic metabolism. Reprod Nutr Dev 1996;36:363-73.
14. 13C-NMR: a simple yet comprehensive method for analysis of intermediary metabolism. Trends Biochem Sci 1991;16:5-10.
15. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982;9:247-8.
16. Brewer CF, Keiser H. Carbon-13 nuclear magnetic resonance study of chondroitin 4-sulfate in the proteoglycan of bovine nasal cartilage. Proc Natl Acad Sci U S A 1975;72:3421-3.
17. 13C nuclear magnetic resonance spectroscopy for sulfate placement in chondroitin sulfates. J Biochem (Tokyo) 1974;76:209-11.
18. 13C NMR investigation of synovial fluids. Magn Reson Med 1993;30:236-40.
19. Cockin GH, Huckerby TN, Nieduszynski IA. High-field n.m.r. studies of keratan sulphates: 1H and 13C assignments of keratan sulphate from shark cartilage. Biochem J 1986;236:921-4.
20. Holme KR, Perlin AS. Nuclear magnetic resonance spectra of heparin in admixture with dermatan sulfate and other glycosaminoglycans: 2-D spectra of the chondroitin sulfates. Carbohydr Res 1989;186:301-12.
21. 13C magnetic resonance. J Biol Chem 1977;252:3617-25.
22. Jelicks LA, Paul PK, O'Byrne E, Gupta RK. Hydrogen-1, sodium-23, and carbon-13 MR spectroscopy of cartilage degradation in vitro. J Magn Reson Imaging 1993;3:565-8.
23. Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 1998;6:427-34.
24. Morales TI, Wahl LM, Hascall VC. The effect of bacterial lipopolysaccharides on the biosynthesis and release of proteoglycans from calf articular cartilage cultures. J Biol Chem 1984;259: 6720-9.
25. Fedders G, Kock R, van de Leur E, Greiling H. The metabolism of 2-fluoro-2-deoxy-D-glucose in human chondrocytes and its incorporation into keratan sulfate proteoglycans. Eur J Biochem 1994;219:1063-71.
26. Hjerpe A, Antonopoulos CA, Engfeldt B. Determination of sulphated disaccharides from chondroitin sulphates by high-performance liquid chromatography. J Chromatogr 1979;171:339-44.
27. Setnikar I. Giacchettic, Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 1986;36: 729-35.
28. Tesoriere G, Dones F, Magistro D, Castagnetta L. Intestinal absorption of glucosamine and N-acetylglucosamine. Experientia 1972;28:770-1.